New guidelines announced to improve cystic fibrosis screening
On Apr. 3, 2025, The International Journal of Neonatal Screening, an international, peer-reviewed journal focused on newborn screening…
Biotechnology | CRISPR | Disease | Genomics | Oncology | Therapeutics
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
Northwestern University announces World’s smallest pacemaker activated by light
On Apr. 2, 2025, Northwestern University engineers announced they have developed a pacemaker so tiny that it can…
Biotechnology | Diagnostics | Disease | Environmental | EPA
Study Finds Rocky Mountain Snow Contamination
On Apr. 1, 2025, Mountain snowpacks accumulate snow throughout the winter, building up stores of water that will…
Biotechnology | Disease | FDA | Rare Disease
FDA Approved Qfitlia™ (fitusiran), the First siRNA (RNAi Therapeutic) for the Treatment of Hemophilia A or B
On Mar. 28, 2025, the U.S. Food and Drug Administration (FDA) announced approval of Alnylam Pharmaceuticals Qfitlia™ (fitusiran),…
Utah becomes the first state to ban fluoride in public drinking water
On Mar. 27, 2025, Utah become the first state to ban fluoride in public drinking water, over opposition…
CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
New antibiotic that kills drug-resistant bacteria discovered in technician’s garden
On Mar. 26, 2025, researchers announced they have discovered a new antibiotic molecule that targets a broad range…
Agriculture | Biotechnology | Diagnostics | Disease | Energy | Environmental | Forestry | Genomics | Medicine | Therapeutics | U.S. Congress
U.S. biotechs warn tariffs could impede access to cures, stifle innovation
On Mar. 26, 2025, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the…
Merck buys rights to heart disease drug in latest China deal worth up to $2 billion
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
GSK’s Blujepa (gepotidacin) approved by U.S. FDA for treatment of uncomplicated urinary tract infections
On Mar. 25, 2025, GSK announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin)…
Biology | Dentistry | Disease | Environmental | Therapeutics
“Milestones in Fluoride” Cartoon Illustrating the Facts behind Natural Mineral Published
On Mar. 24, 2025, LifeScienceHistory.com published the cartoon “Milestones in Fluoride” illustrating the facts behind the naturally occurring…
Study uncovers key role of RNA modifications in prostate cancer progression
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
23andMe Initiates Voluntary Chapter 11 Process to Maximize Stakeholder Value
On Mar. 23, 2025, 23andMe announced that it has initiated voluntary Chapter 11 proceedings in the U.S. Bankruptcy…
Disease | FDA | Rare Disease
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis
On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…
Scientists solve decades-long Parkinson’s mystery
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
Australia’s first durable total artificial heart implant Reported successful
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
Beam Therapeutics Announces Positive Data in Trial Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
Neanderthal Genes linked to lactase persistence in East Asian populations
On Mar. 10, 2025, new research shows positive selection at the 2q21.3 locus in Europeans and Africans has…
Scientists identify genes that make humans and Labradors more likely to become obese
On Mar. 6, 2025, researchers at the University of Cambridge announced they have discovered genes linked to obesity…
Novel Stem Cell Therapy Repairs Irreversible Corneal Damage in Clinical Trial
On Mar. 4, 2025, researchers at a Mass Eye and Ear Institute-led trial announced taking stem cells from…
More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
World first procedure fixes lamb’s leaky heart
On Mar. 3, 2025, researchers from Oregon State University (OSU) announced the world’s first procedure successfully fixes lamb’s…
Arsenic Exposure Linked To Increased Risk Of Kidney Disease
On Mar. 3, 2025, epidemiologists at the Texas A&M University School of Public Health have identified a link…
Biotechnology | Disease | FDA | Medicine | Neurology | Therapeutics
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
New methods reveal cancer mechanism in ancient genes
On Mar. 3, 2025, researchers at Fred Hutch Cancer Center announced they have discovered an overlooked mechanism driving…
Biotechnology | Diagnostics | Disease | FDA | Therapeutics
FDA approves ODACTRA® for the treatment of house dust mite allergy in young children
On Feb. 27, 2025, ALK announced that the U.S. Food and Drug Administration (FDA) has approved ALK’s ODACTRA®…
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion
In Feb. 26, 2025, Eli Lilly announced that it plans to bolster its domestic medicine production across therapeutic…
Breast cancer is on the rise: data reveal drastic gap in survival rates
On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
FDA declares Wegovy® and Ozempic® shortage is over and Supply now exceeds nationwide demand
On Feb. 21, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the…